Drug
atomoxetine (Strattera)
atomoxetine (Strattera) is a pharmaceutical drug with 5 clinical trials. Historical success rate of 80.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_2
1
20%
Ph phase_1
1
20%
Ph phase_4
3
60%
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 43 (60.0%)
Trials by Status
completed480%
terminated120%
Recent Activity
0 active trials
Showing 5 of 5
terminatedphase_1
A Dose Response Effect of Atomoxetine to the Acute Effects of Alcohol
NCT01408589
completedphase_4
A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia
NCT00222794
completedphase_4
Concerta Treatment in Adults With ADHD NOS
NCT00181740
completedphase_4
Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy
NCT00181948
completedphase_2
Effects of Atomoxetine on Cognitive Function in Schizophrenia
NCT00420498
Clinical Trials (5)
Showing 5 of 5 trials
NCT01408589Phase 1
A Dose Response Effect of Atomoxetine to the Acute Effects of Alcohol
NCT00222794Phase 4
A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia
NCT00181740Phase 4
Concerta Treatment in Adults With ADHD NOS
NCT00181948Phase 4
Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy
NCT00420498Phase 2
Effects of Atomoxetine on Cognitive Function in Schizophrenia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5